Press release content from Newswire. The AP news staff was not involved in its creation.
Austin Startup Defies All Odds to Provide Jobs for Creative Professionals
March 12, 2021 GMT
Georgina Elizondo Griffin, Abigail Rose Baez, Albert Baez at Capital Factory, Austin s center of gravity for startups.
Georgina Elizondo Griffin, Abigail Rose Baez, Albert Baez at Capital Factory, Austin s center of gravity for startups.
AUSTIN, Texas - March 12, 2021 - ( Newswire.com )
When Blended Sense began as a lightbulb in actor Abigail Rose’s mind just shy of two years ago, it was an answer to her own palpable, tear-inducing frustrations as a creative professional. Though Abbie worked as an actress in campaigns for national brands like Google, Verizon, and UPS, and starred in feature films like Pasture, she found that consistent, well-paying work was hard to come by. Abbie had to supplement her creative craft with side jobs, and her pay for big acting “gigs” was net 60 to 90 days.
Press release content from Business Wire. The AP news staff was not involved in its creation.
tZERO ATS Forges Agreement with Tokenization Platform DigiShares to Create Path to Liquidity for its Issuer Base
March 11, 2021 GMT
NEW YORK (BUSINESS WIRE) Mar 11, 2021
tZERO, a leader in blockchain innovation and liquidity for digital assets, announced today that its subsidiary, tZERO ATS, a FINRA member broker-dealer that operates an alternative trading system (ATS), has signed an agreement with DigiShares, a white-label platform for tokenized securities, to connect issuers of digital securities on the DigiShares’ platform to the tZERO ATS. DigiShares’ network consists of many asset managers, investment fund managers, real estate developers, renewables project developers, among others that are based in the U.S., Asia, Russia, Europe, and Africa. Interested issuers will now be able to opt in to provide secondary liquidity for their digital securities, subject to tZERO ATS’s due
Press release content from Business Wire. The AP news staff was not involved in its creation.
Desktop Metal and Uniformity Labs Announce Breakthrough in Aluminum Sintering for Binder Jetting Technology
March 11, 2021 GMT
Fully dense, sinterable 6061 aluminum with better than wrought strength will be available for binder jetting technology, marking a significant step forward for the Additive Manufacturing (AM) industry as it is one of the most sought-after materials for use in automotive, aerospace and consumer electronics. (Photo: Business Wire)
Fully dense, sinterable 6061 aluminum with better than wrought strength will be available for binder jetting technology, marking a significant step forward for the Additive Manufacturing (AM) industry as it is one of the most sought-after materials for use in automotive, aerospace and consumer electronics. (Photo: Business Wire)
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Kratos Defense & Rocket Support Services Supports Successful Sounding Rocket Launch of AFRL .
Kratos Defense & Security Solutions, Inc.March 12, 2021 GMT
SAN DIEGO, March 12, 2021 (GLOBE NEWSWIRE) Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leading National Security Solutions provider, announced today that its Sounding Rocket Program (SRP)-4 launch vehicle team under subcontract to Space Vector Corporation, successfully launched a scientific experiment for the U.S. Space Force Space and Missile Systems Center’s Launch Enterprise from the Wallops Flight Facility in Virginia. It was the first launch of a sounding rocket vehicle under SRP-4, an indefinite delivery/indefinite quantity contract that was awarded to the Space Vector Corporation in partnership with Kratos in December of 2018.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Evoke Pharma Reports Fourth Quarter and Full Year 2020 Financial Results
Evoke Pharma, Inc.March 11, 2021 GMT
SOLANA BEACH, Calif., March 11, 2021 (GLOBE NEWSWIRE) Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter ended December 31, 2020 and recent corporate developments.
“Despite the challenges precipitated by the COVID-19 pandemic, 2020 proved to be a transformative year for Evoke as we initiated the commercial launch of GIMOTI™ for acute and recurrent diabetic gastroparesis with our commercial partner EVERSANA,” stated David A. Gonyer, R.Ph., President and CEO of Evoke Pharma. “We are encouraged by the early traction we are seeing in GIMOTI sales and the feedback we are receiving from gastroenterologists, which was further ill